Rybelsus 14mg Tablet contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Benefits
Rybelsus 14mg Tablet effectively lowers blood sugar and A1C levels in adults with type 2 diabetes. It also helps reduce the risk of major cardiovascular events such as heart attack, stroke, or death in high-risk adults with type 2 diabetes. While not specifically approved for weight loss, some individuals may experience weight reduction during treatment.
Uses and Indications
- To improve glycemic control in adults with type 2 diabetes mellitus, used alongside diet and exercise.
- To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events.
